PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 27, 2024Clinical Case Reports0 citationsOpen Access

Paget's bone disease in a nonendemic region: Exploring novel therapeutic strategies

View Full Paper
NRNasrin RazavianzadehSSSoheil ShahramiradMHMohammad Hasani

Key Points

Key points are not available for this paper at this time.

Abstract

Paget's disease of bone (PDB) is a chronic condition causing abnormal bone remodeling, leading to pain, fractures, and complications. A 57-year-old female patient, asymptomatic and devoid of pain, incidentally exhibited elevated levels of alkaline phosphatase. Following a thorough consideration of potential differential diagnoses, the eventual diagnosis established was PDB. We recommended Fosamax (70 mg alendronate tablets) at two tablets twice weekly for 3 months to manage PDB due to patient preference and side effects with intravenous zoledronic acid. Subsequent assessments of alkaline phosphatase levels during follow-up examinations post-treatment revealed a reduction in their values.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Razavianzadeh et al. (2024) studied this question.

synapsesocial.com/papers/68e5ac8db6db643587546439https://doi.org/10.1002/ccr3.9364
Ask AI
Helpful
Bookmark
Share
View Full Paper